Picture of LifeMD logo

LFMD LifeMD News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

LifeMD Inc reports results for the quarter ended in March - Earnings Summary

* LifeMD Inc  LFMD.OQ  reported a quarterly adjusted loss
of 15
cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 16 cents per
share.
    * Revenue rose 14.1% to $33.13 million from a year ago;
analysts
expected $30.80 million. 
    * LifeMD Inc's reported EPS for the quarter was a loss of 15
cents​.
    * The mean earnings estimate of analysts had risen by
about 11.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * LifeMD Inc shares had risen by 7.6% this quarter and
lost 5.7%
so far this year.
    * The company reported a quarterly loss of $4.79 million.
    * Wall Street's median 12-month price target for LifeMD Inc
is
$7.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.16          -0.15          Beat
 Dec. 31 2022      -0.18          -0.40          Missed
 Sep. 30 2022      -0.28          -0.26          Beat
 Jun. 30 2022      -0.35          -0.45          Missed

Recent news on LifeMD

See all news